Globe Newswire

ROSEN, LEADING INVESTOR COUNSEL, Encourages Exscientia p.l.c Investors to Secure Counsel Before Important Deadline in Securities Class Action – EXAI May 8, 2024 08:23PM

NEW YORK, May 08, 2024 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Exscientia p.l.c (NASDAQ: EXAI) between March 23, 2022 and February 12, 2024, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 25, 2024.

SO WHAT: If you... (continue reading...)

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Intel Corporation with Losses to Contact the Firm May 8, 2024 08:17PM

LOS ANGELES, May 08, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Intel Corporation (“Intel” or “the Company”) (NASDAQ: INTC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company’s securities between January 25,... (continue reading...)

Western Forest Products Inc. Announces Election of Directors May 8, 2024 08:03PM

VANCOUVER, British Columbia, May 08, 2024 (GLOBE NEWSWIRE) -- Western Forest Products Inc. (TSX: WEF) (“Western” or the “Company”) announces the following voting results in respect of the election of directors at its Annual Meeting of Shareholders (the “Meeting”) held today:

Name of NomineeVotes For% ForVotes Against% AgainstLaura A. Cillis187,242,63788.96%23,246,58811.04%Steven Hofer192,441,53891.43%18,047,6878.57%Randy... (continue reading...)

Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering May 8, 2024 08:00PM

SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D) human tissues, today announced the pricing of a public offering consisting of 6,562,500 shares of common stock (or pre-funded warrants in lieu thereof) and common warrants to purchase up to an... (continue reading...)

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against DoubleVerify Holdings, Inc. and Encourages Investors to Contact the Firm May 8, 2024 07:22PM

LOS ANGELES, May 08, 2024 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of DoubleVerify Holdings, Inc. (“DoubleVerify” or “the Company”) (NYSE: DV) for violations of the securities laws.

The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. DoubleVerify... (continue reading...)